These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33594533)

  • 21. Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability.
    Wilkinson CL; Nelson CA
    Mol Autism; 2021 Feb; 12(1):17. PubMed ID: 33632320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.
    Rotschafer SE; Trujillo MS; Dansie LE; Ethell IM; Razak KA
    Brain Res; 2012 Feb; 1439():7-14. PubMed ID: 22265702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
    Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
    Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of binding and inhibitory properties of TAK-063, a novel phosphodiesterase 10A inhibitor.
    Harada A; Suzuki K; Kamiguchi N; Miyamoto M; Tohyama K; Nakashima K; Taniguchi T; Kimura H
    PLoS One; 2015; 10(3):e0122197. PubMed ID: 25815469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT
    Saraf TS; McGlynn RP; Bhatavdekar OM; Booth RG; Canal CE
    ACS Chem Neurosci; 2022 Dec; 13(24):3629-3640. PubMed ID: 36473166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.
    Nguyen AO; Binder DK; Ethell IM; Razak KA
    J Neurophysiol; 2020 Jun; 123(6):2101-2121. PubMed ID: 32319849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensory Processing Phenotypes in Fragile X Syndrome.
    Rais M; Binder DK; Razak KA; Ethell IM
    ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Excitatory Connectivity and Disturbed Sound Processing in the Auditory Brainstem of Fragile X Mice.
    Garcia-Pino E; Gessele N; Koch U
    J Neurosci; 2017 Aug; 37(31):7403-7419. PubMed ID: 28674175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486.
    Dolan BM; Duron SG; Campbell DA; Vollrath B; Shankaranarayana Rao BS; Ko HY; Lin GG; Govindarajan A; Choi SY; Tonegawa S
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5671-6. PubMed ID: 23509247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington's Disease.
    Harada A; Suzuki K; Kimura H
    J Pharmacol Exp Ther; 2017 Jan; 360(1):75-83. PubMed ID: 27811172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of sound exposure on auditory cortex development in a mouse model of Fragile X Syndrome.
    Kulinich AO; Reinhard SM; Rais M; Lovelace JW; Scott V; Binder DK; Razak KA; Ethell IM
    Neurobiol Dis; 2020 Feb; 134():104622. PubMed ID: 31698054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Audiogenic Seizures in the
    Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
    J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered auditory processing in a mouse model of fragile X syndrome.
    Rotschafer S; Razak K
    Brain Res; 2013 Apr; 1506():12-24. PubMed ID: 23458504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAK-063, a phosphodiesterase 10A inhibitor, modulates neuronal activity in various brain regions in phMRI and EEG studies with and without ketamine challenge.
    Tomimatsu Y; Cash D; Suzuki M; Suzuki K; Bernanos M; Simmons C; Williams SC; Kimura H
    Neuroscience; 2016 Dec; 339():180-190. PubMed ID: 27725212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
    Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
    J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models.
    Shiraishi E; Suzuki K; Harada A; Suzuki N; Kimura H
    J Pharmacol Exp Ther; 2016 Mar; 356(3):587-95. PubMed ID: 26675680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.
    Olmos-Serrano JL; Corbin JG; Burns MP
    Dev Neurosci; 2011; 33(5):395-403. PubMed ID: 22067669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.
    Ferraguto C; Piquemal-Lagoueillat M; Lemaire V; Moreau MM; Trazzi S; Uguagliati B; Ciani E; Bertrand SS; Louette E; Bontempi B; Pietropaolo S
    Neuropsychopharmacology; 2024 Dec; 49(13):2032-2041. PubMed ID: 39223257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the
    Premoli M; Fyke W; Bellocchio L; Lemaire V; Wolley-Roberts M; Bontempi B; Pietropaolo S
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.